ZBP-89 and Sp1 contribute to Bak expression in hepatocellular carcinoma cells
Open Access
- 13 April 2018
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 18 (1) , 419
Abstract
Kruppel family member zinc binding protein 89 (ZBP-89), also known as ZNF148, regulates Bak expression via binding to GC-rich promoter domain. It is not clear if other GC-rich binding factors, such as Sp family members, can interact with ZBPp-89 on Bak expression. This study aims to elucidate the mechanism of Bak expression regulation by ZBP-89 and Sp proteins, based on in vitro experiment and The Cancer Genome Atlas (TCGA) hepatocellular carcinoma (HCC) data cohort. We downloaded TCGA hepatocellular carcinoma (HCC) cohort data to analysis the association of Bak transcription level with ZBP-89 and Sp proteins transcription level. HCC cell lines and liver immortal non-tumour cell lines were used for mechanism study, including western blotting analysis, expression vector mediated gene expression and siRNA interference. Results showed that cancer tissues have higher Bak transcription level compared with adjacent non-cancer tissues. Bak transcription level was correlated with Sp1 and Sp3 expression level, while no correlation was found in ZBP-89 and Bak, neither Sp2 nor Sp4. Mithramycin A (MMA) induced Bak expression in a dose-dependent manner. Western blotting results showed Sp1 overexpression increased Bak expression both in liver immortal non-tumour cells and HCC cells. Interference Sp1 expression could inhibit Bak expression alone. ZBP-89 siRNA suppressed Bak expression even in the presence of MMA treatment and S1 overexpression. Additionally, Bak and Sp1 level were associated with HCC patient survival. Bak expression required ZBP-89 and Sp1 cooperative regulation simultaneously.Keywords
Funding Information
- National Natural Science Foundation of China (81572782)
- Special Talent Supportive Grant (4TZ160001G)
This publication has 31 references indexed in Scilit:
- Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent ‘type I’ modeCell Death & Disease, 2013
- Identification of novel Sp1 targets involved in proliferation and cancer by functional genomicsBiochemical Pharmacology, 2012
- Promoter cloning and characterization of the human programmed cell death protein 4 (pdcd4) gene: evidence for ZBP-89 and Sp-binding motifs as essential Pdcd4 regulatorsBioscience Reports, 2012
- Histone Deacetylase Inhibitors and Mithramycin A Impact a Similar Neuroprotective Pathway at a Crossroad between Cancer and NeurodegenerationPharmaceuticals, 2011
- Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signalingHepatology, 2010
- BH3-only proteins in apoptosis and beyond: an overviewOncogene, 2008
- Sp1: Emerging roles—Beyond constitutive activation of TATA-less housekeeping genesBiochemical and Biophysical Research Communications, 2008
- SP-transcription factors are involved in basal MVP promoter activity and its stimulation by HDAC inhibitorsBiochemical and Biophysical Research Communications, 2004
- The Zinc Finger Repressor, ZBP-89, Binds to the Silencer Element of the Human Vimentin Gene and Complexes with the Transcriptional Activator, Sp1Journal of Biological Chemistry, 2000
- Identification of the DNA sequence that interacts with the gut-enriched Kruppel-like factorNucleic Acids Research, 1998